ArticleMolecules (Basel, Switzerland)2026

Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16A.

Lu Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.